Tounsi Nabila, Djerdjouri Bahia, Bouzid Chafik, Bentabak Kamel
University of Sciences and Technology Houari Boumediene, Faculty of Biological Sciences, Laboratory of Cellular and Molecular Biology, Algiers, Algeria.
Mustapha Pacha Hospital, Public Health Center Pierre and Marie Curie, Department of Oncological Surgery A, Algiers, Algeria.
J Appl Biomed. 2019 Sep;17(3):175-183. doi: 10.32725/jab.2019.016. Epub 2019 Sep 17.
This study investigates serum redox status and adenosine catabolism markers in relation to tumor and angiogenesis, in patients with gallbladder carcinoma (GBC). The level of adenosine deaminase (ADA) and xanthine oxidase (XO) activities, nitrites (NO2), glutathione (GSH) and malondialdehyde (MDA) were measured in sera of 40 GBC patients and 40 healthy donors. In parallel, 15 tumors at TNM stage IV were scored for CD34 expression and microvessel density (MVD). The results showed that XO and ADA activities, nitrites and MDA levels enhanced by 1.26 (p < 0.01), 2.69, 2.0, and 3.2-fold (p < 0.001), respectively, while those of GSH decreased by 44.6% (p < 0.001). According to receiver operating characteristic (ROC) curve, the optimal cut-off for XO, ADA, MDA, GSH and nitrites were 5.41U/l, 17.02 U/l, 3.72 μM, 36.91 μM and 21.21 μM, respectively. Spearman correlation revealed that ADA activity correlated to nitrites levels (r = 0.3419, p < 0.05) and XO activity (r = 0.5487, p < 0.001). Multivariate binary logistic regression analysis revealed that MDA (OR = 5.78, p < 0.05), ADA (OR = 1.28, p < 0.001) and XO (OR = 2.81, p < 0.05) correlated positively to GBC. CD34 was up expressed in 73.3% of tumors at intermediate to high levels. Multiple regression analysis showed that ADA affected MVD (r = 0.604, p < 0.01). The results suggest that high MDA/GSH ratio is a potential biomarker of GBC. In addition, the oxidative adenosine catabolism indicated that active purine salvage pathway could support tumor progression by sustaining angiogenesis.
本研究调查了胆囊癌(GBC)患者血清氧化还原状态和腺苷分解代谢标志物与肿瘤及血管生成的关系。检测了40例GBC患者和40例健康供体血清中腺苷脱氨酶(ADA)和黄嘌呤氧化酶(XO)活性、亚硝酸盐(NO2)、谷胱甘肽(GSH)和丙二醛(MDA)水平。同时,对15例TNM IV期肿瘤的CD34表达和微血管密度(MVD)进行评分。结果显示,XO和ADA活性、亚硝酸盐和MDA水平分别升高了1.26倍(p < 0.01)、2.69倍、2.0倍和3.2倍(p < 0.001),而GSH水平降低了44.6%(p < 0.001)。根据受试者工作特征(ROC)曲线,XO、ADA、MDA、GSH和亚硝酸盐的最佳截断值分别为5.41U/l、17.02 U/l、3.72 μM、36.91 μM和21.21 μM。Spearman相关性分析显示,ADA活性与亚硝酸盐水平(r = 0.3419,p < 0.05)和XO活性(r = 0.5487,p < 0.001)相关。多因素二元逻辑回归分析显示,MDA(OR = 5.78,p < 0.05)、ADA(OR = 1.28,p < 0.001)和XO(OR = 2.81,p < 0.05)与GBC呈正相关。73.3%的肿瘤中CD34在中高水平表达。多元回归分析显示,ADA影响MVD(r = 0.604,p < 0.01)。结果表明,高MDA/GSH比值是GBC的潜在生物标志物。此外,氧化腺苷分解代谢表明,活跃的嘌呤补救途径可通过维持血管生成来支持肿瘤进展。